Single-cell mutation identification via phylogenetic inference.
Jochen SingerJack KuipersKatharina JahnNiko BeerenwinkelPublished in: Nature communications (2018)
Reconstructing the evolution of tumors is a key aspect towards the identification of appropriate cancer therapies. The task is challenging because tumors evolve as heterogeneous cell populations. Single-cell sequencing holds the promise of resolving the heterogeneity of tumors; however, it has its own challenges including elevated error rates, allelic drop-out, and uneven coverage. Here, we develop a new approach to mutation detection in individual tumor cells by leveraging the evolutionary relationship among cells. Our method, called SCIΦ, jointly calls mutations in individual cells and estimates the tumor phylogeny among these cells. Employing a Markov Chain Monte Carlo scheme enables us to reliably call mutations in each single cell even in experiments with high drop-out rates and missing data. We show that SCIΦ outperforms existing methods on simulated data and applied it to different real-world datasets, namely a whole exome breast cancer as well as a panel acute lymphoblastic leukemia dataset.
Keyphrases
- single cell
- rna seq
- induced apoptosis
- acute lymphoblastic leukemia
- high throughput
- cell cycle arrest
- big data
- endoplasmic reticulum stress
- signaling pathway
- stem cells
- monte carlo
- dna methylation
- gene expression
- mesenchymal stem cells
- machine learning
- copy number
- papillary thyroid
- young adults
- cell therapy
- artificial intelligence
- deep learning
- allogeneic hematopoietic stem cell transplantation
- childhood cancer